Peptides merchant accounts.
Peptide and research-chemical businesses face the heaviest documentation burden in high risk. Boarding depends on how precisely you label and describe what you sell.
Request a reviewWhy this category is classified high risk
Products sold for research use exist in a gray zone that underwriters examine closely, and any drift toward human-use or therapeutic claims ends most applications.
Regulatory classification is ambiguous and varies by compound, so acquirers demand exact product descriptions and intended-use labeling.
The category attracts scrutiny for mislabeling, so legitimate sellers face extra documentation to prove they aren't.
What underwriting will want to see
- Research-use-only labeling and site language, with no dosing, medical, or human-consumption claims anywhere.
- Clear compound descriptions and, where relevant, purity documentation or COAs.
- Disclaimers and terms that a customer affirmatively accepts at checkout.
- Standard financials plus a detailed catalog for underwriting review.
What drives disputes here
'Not as described' disputes arise when purity or labeling expectations aren't met — documentation and accurate listings are the defense.
Non-recognition on rebills or repeat orders appears; recognizable descriptors reduce it.
Shipping and customs delays on specialized products generate 'not received' claims that tracking resolves.
Descriptor & billing guidance
Use a neutral descriptor tied to the business name and keep receipts consistent with the research-use framing on the site. Retain labeling and purity documentation with each order — in this category, the paper trail is what defends both the account and the dispute.
Peptides, specifically
- Will my site language affect approval?
- More than almost anything else. Research-use-only framing with zero human-use or dosing claims is what makes these accounts boardable. Therapeutic language is the most common reason peptide applications are declined.
- Do I need purity documentation?
- Where it's relevant to what you sell, yes. COAs or purity data on file support underwriting and help defend 'not as described' disputes.
- Is this category stable long term?
- It can be, provided your labeling and marketing stay disciplined. The accounts that get closed are the ones that drift into claims they can't make.
Tell us about your business. We'll tell you who will board it.
Describe what you actually sell and how you deliver it. We'll match you to an acquirer that wants the volume — or tell you plainly if it won't board.